All compounds demonstrated the inhibition of the cancer-related hCA isoforms IX and XII with Ki values in the nanomolar range and were shown to be devoid of any inhibitory activity toward the cytosolic hCA I and hCA II up to 10 μM concentration in the assay system. Here, CYP24A1 is linked to cancer.